Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.
Saved in:
| Title: | Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial. |
|---|---|
| Authors: | Dunbar J; Sage Therapeutics, Inc., Cambridge, MA, USA., Walling DP; CenExel CNS, Los Alamitos, CA, USA., Hassman HA; CenExel Hassman Research Institute, Marlton, NJ, USA., Jain R; Texas Tech University School of Medicine, Austin, TX, USA., Czysz A; Sage Therapeutics, Inc., Cambridge, MA, USA., Nandy I; Sage Therapeutics, Inc., Cambridge, MA, USA., Ona V; Sage Therapeutics, Inc., Cambridge, MA, USA., Moseley MK; Biogen, Inc., Cambridge, MA, USA., Levin S; Biogen, Inc., Cambridge, MA, USA., Maruff P; Cogstate, New Haven, CT, USA. |
| Source: | Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2024 Dec; Vol. 38 (12), pp. 1122-1136. Date of Electronic Publication: 2024 Oct 11. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
